274 related articles for article (PubMed ID: 17980093)
1. Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.
Freitas LL; Soriano E; Muccioli C; Höfling-Lima AL; Belfort R
Curr Med Res Opin; 2007 Dec; 23(12):3123-30. PubMed ID: 17980093
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
Belfort R; Gabriel L; Martins Bispo PJ; Muccioli C; Zacharias Serapicos PC; Clark L; Bell B; Bartell J; Stroman DW; Höfling-Lima AL
Adv Ther; 2012 May; 29(5):416-26. PubMed ID: 22562783
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification.
Wadood AC; Armbrecht AM; Aspinall PA; Dhillon B
J Cataract Refract Surg; 2004 Apr; 30(4):761-8. PubMed ID: 15093636
[TBL] [Abstract][Full Text] [Related]
4. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients.
Espiritu CR; Caparas VL; Bolinao JG
J Cataract Refract Surg; 2007 Jan; 33(1):63-8. PubMed ID: 17189795
[TBL] [Abstract][Full Text] [Related]
5. Phase II results of an intraocular steroid delivery system for cataract surgery.
Chang DF; Garcia IH; Hunkeler JD; Minas T
Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
[TBL] [Abstract][Full Text] [Related]
6. Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.
Arbisser LB
J Cataract Refract Surg; 2008 Jul; 34(7):1114-20. PubMed ID: 18571078
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.
Lane SS; Osher RH; Masket S; Belani S
J Cataract Refract Surg; 2008 Sep; 34(9):1451-9. PubMed ID: 18721703
[TBL] [Abstract][Full Text] [Related]
8. Two clinical trials of an intraocular steroid delivery system for cataract surgery.
Chang DF; Wong V
Trans Am Ophthalmol Soc; 1999; 97():261-74; discussion 274-9. PubMed ID: 10703128
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1383-8. PubMed ID: 18655992
[TBL] [Abstract][Full Text] [Related]
12. A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery.
Paganelli F; Cardillo JA; Melo LA; Lucena DR; Silva AA; Oliveira AG; Höfling-Lima AL; Nguyen QD; Kuppermann BD; Belfort R;
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3041-7. PubMed ID: 19234342
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgery.
Russo S; Papa V; Di Bella A; Favero A; Radulescu C; Gafencu O; Carstocea B; Milazzo G
Eye (Lond); 2007 Jan; 21(1):58-64. PubMed ID: 16273088
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery.
Raizman MB; Donnenfeld ED; Weinstein AJ
Curr Med Res Opin; 2007 Oct; 23(10):2325-31. PubMed ID: 17697456
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerability of a combination of indomethacin and gentamicin for preventing inflammation after cataract surgery].
Renard G; Adenis JP; Rouland JF; Dascotte JC; Brasseur G; Couderc JL; Hoang-Xuan T; Ullern M; Allaire C; Trinquand C
J Fr Ophtalmol; 1996; 19(11):689-95. PubMed ID: 9033890
[TBL] [Abstract][Full Text] [Related]
17. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
Asano S; Miyake K; Ota I; Sugita G; Kimura W; Sakka Y; Yabe N
J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
[TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
[TBL] [Abstract][Full Text] [Related]
19. Anterior chamber depth and change in axial intraocular lens position after cataract surgery with primary posterior capsulorhexis and posterior optic buttonholing.
Stifter E; Menapace R; Luksch A; Neumayer T; Sacu S
J Cataract Refract Surg; 2008 May; 34(5):749-54. PubMed ID: 18471628
[TBL] [Abstract][Full Text] [Related]
20. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
